NCT01582373

Brief Summary

The current pilot study aims to assess the feasibility and preliminary efficacy of a novel, 12-week targeted couple intervention (CBCT) for women with vulvodynia and their partners.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 20, 2012

Completed
11 days until next milestone

Study Start

First participant enrolled

May 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

December 3, 2014

Status Verified

December 1, 2014

Enrollment Period

1 year

First QC Date

April 19, 2012

Last Update Submit

December 1, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain during intercourse (Visual analog scale)

    Pain during intercourse will be assessed using a visual analog scale (VAS) ranging from 0 to 10, where 0 is no pain at all, and 10 is the worst pain ever. The main outcome will be the change in the VAS scores from pre- to post-treatment. This method for measuring pain has been shown to detect significant treatment effects in women with PVD and demonstrates a significant positive correlation with other pain intensity measures. Pain during intercourse is the main symptom of PVD and the one that most interferes with quality of life, hence the most relevant measure of functional outcome.

    change in the VAS scores from pre- to post-treatment, and from pre-treatment to 3-month post-treatment

Secondary Outcomes (9)

  • Sexual function (Derogatis Interview for Sexual Functioning - Self-Report)

    change in the DISF-SR scores from pre- to post-treatment, and from pre-treatment to 3-month post-treatment

  • Global Measure of Sexual Satisfaction scale

    change in GMSEX scores from pre-to post-treatment, and from pre-treatment to 3-month post-treatment

  • West Haven-Yale Multidimensional Pain Inventory - Significant Other Response Scale (MPI)

    changes in MPI scores from pre- to post-treatment, and from pre-treatment to 3-month post-treatment

  • Couple Satisfaction Index (CSI)

    changes in CSI scores from pre- to post-treatment, and from pre-treatment to 3-month post-treatment

  • Pain Catastrophizing Scale (PCS)

    changes in PSC scores from pre-to post-treatment, and from pre-treatment to 3-month post-treatment

  • +4 more secondary outcomes

Study Arms (1)

Cognitive-behavioral couple therapy

EXPERIMENTAL

The goals of CBCT are to enable participants to: (1) re-conceptualize PVD as a multidimensional pain problem influenced by a variety of factors including thoughts, emotions, behaviors and couple interactions; (2) re-conceptualize PVD as a couple problem in which both members of the couple affect and are affected by the pain; (3) modify those factors associated with pain during intercourse with a view to increasing adaptive coping, for example, by increasing self-efficacy and decreasing catastrophizing, as well as decreasing pain intensity; (4) improve the quality of their sexual functioning, reduce their sexual distress and increase their sexual satisfaction; (5) consolidate skills.

Behavioral: Cognitive-behavioral couple therapy

Interventions

The treatment package will include the following: information about the nature of CBCT; education about PVD and how it impacts on sexuality; education concerning a multifactorial view of pain; relaxation techniques; vaginal dilatation exercises; cognitive restructuring exercises (replacing distorted or irrational beliefs about pain and sexuality by more realistic ones); distraction techniques focusing on sexual imagery; expansion of the sexual repertoire; and exercises to improve pain and sexuality-relevant couple interactions (e.g., communication skills training, modification of maladaptive partner responses to pain, emotional disclosure and validation exercises).

Also known as: Cognitive Behavioral Pain and Sex Therapy (CBPST)
Cognitive-behavioral couple therapy

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • pain during intercourse which is a) subjectively distressing, b) occurs on 80% of intercourse attempts, and c) has lasted for at least one year
  • pain limited to intercourse and other activities involving pressure to the vestibule
  • significant pain in one or more locations of the vestibule during the gynaecological exam, which is operationalized as a minimum average patient pain rating of 4 on a scale of 0 to 10
  • having been sexually active as a couple in the last three months (intercourse, manual or oral stimulation)
  • in a committed relationship for at least six months

You may not qualify if:

  • vulvar pain not clearly linked to intercourse or pressure applied to the vestibule
  • presence of one of the following: a) major medical and/or psychiatric illness, b) active infection, c) deep dyspareunia, d) vaginismus (as defined by DSM-IV), e) dermatologic lesion, f) pregnancy or planning a pregnancy
  • age less than 18 or greater than 45

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université de Montréal

Montreal, Quebec, H3C 3J7, Canada

Location

MeSH Terms

Conditions

Vulvodynia

Condition Hierarchy (Ancestors)

Vulvar DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Sophie Bergeron, PhD

    Université de Montréal

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

April 19, 2012

First Posted

April 20, 2012

Study Start

May 1, 2012

Primary Completion

May 1, 2013

Study Completion

December 1, 2014

Last Updated

December 3, 2014

Record last verified: 2014-12

Locations